| Vial description: |
purified alpha Actinin 4 Blocking Peptide |
| Antibody's or peptide concentration: |
ug/ml in stabilization buffer |
| Raised in: |
sterile environment |
| Reactivity: |
specific antigen |
| Immunogen: |
Synthetic peptide taken within amino acid region 140see msds190 on human Alpha Actinin 4 protein |
| Antigen or peptide: |
alpha Actinin 4 |
| Original name: |
alpha Actinin 4 Blocking Peptide |
| Phosphorylation: |
Non phosphorylated |
| Epitope: |
specific sequence |
| Type: |
Antigenic Blocking Peptide |
| Antibody's relevance: |
Immunocompetition, Immunodepletion |
| Antibody's application: |
Immunocompetition, Immunodepletion |
| Storage conditions: |
-20⁰C for long term storage |
| Genbank number: |
NP_004915 |
| Protein number: |
O43707 |
| Test: |
You can block the antibody by the specific target amino acid sequence of peptide |
| Gene target: |
alpha Actinin 4 |
| Short name: |
alpha Actinin 4 Blocking Peptide sequence |
| Technique: |
blocking peptides, Blocking |
| Alternative name: |
a Actinin 4 inhibiting short protein sequence sequence |
| Alternative technique: |
control |
| Identity: |
44032 |
| Gene: |
ACTN4P2 |
More about : ACTN4P2 |
| Long gene name: |
actinin alpha 4 pseudogene 2 |
| Locus: |
1p34, 3 |
| Discovery year: |
2012-05-28 |
| Entrez gene record: |
391026 |
| Havana BLAST/BLAT: |
OTTHUMG00000004315 |